Trial Profile
Clinical Trials Insight: 700058174
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2010
Price :
$35
*
At a glance
- Drugs Sabcomeline (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors BrainCells
- 06 Aug 2010 New trial record